epirubicin has been researched along with Glioma in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Bhandari, A; Kaur, G; Kaur, H; Kaur, M; Sharma, I; Singh, H; Singh, P | 1 |
| Hong, W; Kong, D; Li, Y; Ying, X; Yu, M; Zheng, Y | 1 |
| Chen, S; Chen, X; Chen, Y; Gu, Y; Hu, M; Li, W; Liu, D; Ma, Y; Shen, Y; Sun, L; Xu, Y | 1 |
| Daniels, RL; Phelps, MC; Tavener, AM | 1 |
| Chen, PY; Hsu, SC; Huang, CY; Lin, CW; Lin, KJ; Liu, HL; Lu, YJ; Ma, CC; She, SH; Wei, KC; Wey, SP; Xiao, MC; Yang, HW; Yen, TC | 1 |
| Chen, MH; Jiang, CL; Li, YL; Wang, XF; Yuan, QH; Zhao, ZF | 1 |
| Hu, YJ; Ju, RJ; Liu, L; Lu, WL; Mu, LM; Wu, JS; Xie, HJ; Yan, Y; Zeng, F; Zhao, Y | 1 |
| Allameh, A; Kazemi, B; Maleklou, N | 1 |
| Dong, Z; Lou, J; Xu, L; Yang, J; Yang, Q | 1 |
| Bekelis, K; Brem, H; Hertig, S; Kosztowski, T; Legnani, FG; Li, KW; Olivi, A; Recinos, VR; Tyler, BM; Vick, D; Ziegler, SG | 1 |
| Du, J; Guo, J; Li, RJ; Lou, JN; Lu, WL; Men, Y; Tian, W; Yao, HJ; Ying, X; Zhang, LR; Zhang, Y | 1 |
| Nakazawa, S; Takahashi, H; Zhu, J | 1 |
| Ninjo, SS; Todorov, DK; Zeller, WJ | 1 |
| Ames, MM; Kuffel, MJ; Reid, JM | 1 |
| Ulmer, W | 1 |
| Robert, J; Schott, B | 1 |
16 other study(ies) available for epirubicin and Glioma
| Article | Year |
|---|---|
Structural tuning of acridones for developing anticancer agents targeting dihydrofolate reductase.
Topics: Acridones; Antineoplastic Agents; Apoptosis; Cell Proliferation; Enzyme Inhibitors; Glioma; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Tumor Cells, Cultured | 2019 |
Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas.
Topics: Animals; Brain; Cell Line, Tumor; Epirubicin; Glioma; Humans; Liposomes; Rats; Resveratrol | 2022 |
Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; DNA; Drug Carriers; Drug Delivery Systems; Epirubicin; Glioma; Humans; Mice; Mice, Nude; Microbubbles | 2022 |
Anthracycline-induced cytotoxicity in the GL261 glioma model system.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Comet Assay; Cytotoxins; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Glioma; Humans; Idarubicin; Mice; Models, Biological; Neuroglia | 2021 |
EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Immobilized; Cell Line, Tumor; Combined Modality Therapy; Drug Carriers; Drug Delivery Systems; Epirubicin; ErbB Receptors; Glioma; Graphite; Humans; Mice; Nanostructures; Oxides; Phototherapy; Polyethylene Glycols | 2013 |
Epirubicin inhibits growth and alters the malignant phenotype of the U‑87 glioma cell line.
Topics: Antibiotics, Antineoplastic; Biomarkers; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytoskeleton; Epirubicin; Glioma; Humans; Matrix Metalloproteinase 9; Phenotype; Vascular Endothelial Growth Factor A | 2015 |
Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Caspase 8; Celecoxib; Cell Line, Tumor; Epirubicin; Glioma; Humans; Liposomes; Male; Mice, Nude; Neoplasm Recurrence, Local | 2016 |
Targeted delivery of vitamin D3-loaded nanoparticles to C6 glioma cell line increased resistance to doxorubicin, epirubicin, and docetaxel in vitro.
Topics: AC133 Antigen; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Cholecalciferol; DNA; Docetaxel; Doxorubicin; Drug Delivery Systems; Epirubicin; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; L-Lactate Dehydrogenase; Nanoparticles; Rats; Taxoids | 2016 |
An epirubicin-peptide conjugate with anticancer activity is dependent upon the expression level of the surface transferrin receptor.
Topics: Amino Acid Sequence; Antigens, CD; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Survival; Epirubicin; Glioma; Humans; Peptides; Receptors, Transferrin | 2017 |
Epirubicin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Delivery Systems; Epirubicin; Female; Glioma; Humans; Polymers; Rats; Rats, Inbred F344; Tetrazolium Salts; Thiazoles; Time Factors | 2010 |
Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Coculture Techniques; Epirubicin; Glioma; Liposomes; Mice; Rats; Rats, Wistar | 2010 |
Human monoclonal antibody-drug conjugates in the experimental treatment of malignant gliomas--studies in vitro and in vivo.
Topics: Animals; Antibodies, Monoclonal; Blood-Brain Barrier; Brain Neoplasms; Doxorubicin; Epirubicin; Glioma; Humans; Immunotoxins; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1994 |
Antiproliferative activity of liposomal epirubicin on experimental human gliomas in vitro and in vivo after intratumoral/interstitial application.
Topics: Animals; Epirubicin; Female; Glioma; Humans; Liposomes; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1995 |
Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
Topics: Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Epirubicin; Glioma; Humans; Idarubicin; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1992 |
Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 2: Dose-effect relationships and 31P NMR spectroscopy of L 1210 cells (monolayers) and 9L glioma cells (monolayers and tumor spheroids) treated with activated is
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biophysical Phenomena; Biophysics; Cell Line; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Electrons; Epirubicin; Glioma; Hydrogen-Ion Concentration; Ifosfamide; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Radiotherapy Dosage; Rats; Time Factors; Tumor Cells, Cultured | 1991 |
Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Resistance; Epirubicin; Glioma; Rats; Tumor Cells, Cultured | 1989 |